CoLabs

SCOPE
Create an emergency airway and ventilation system for cardiac arrest situations, simple enough for a child to operate. Produce small lot of development-stage product for a low-cost cytotoxicity study, in order to achieve confidence for ensuing biocompatibility tests.
OUTCOME
The device demonstrated success in cytotoxicity tests and is now moving on to clinical stages. CoLabs won the LSI pitch competition in 2022 and has postured itself for incredible market success and strategic buyer interest.

Meet Our Team

Get in touch with us today to see how we can help you achieve your goals.